Raymond James & Associates Exscientia PLC Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$5.3 - $10.93 $110,388 - $227,650	20,828 New	20,828 $110,000
Q3 2022 Oct 25, 2022	SELL	$7.27 - $12.92 $2,384 - $4,237	-328 Reduced 2.82%	11,283 $93,000
Q2 2022 Aug 12, 2022	SELL	$6.92 - $15.97 $7,106 - $16,401	-1,027 Reduced 8.13%	11,611 $126,000
Q1 2022 May 11, 2022	BUY	$11.52 - $22.05 $145,589 - $278,667	12,638 New	12,638 $182,000

101

33.5M

500

189K

Ticker EXAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,461,000
Market Cap $593M
Description
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.